Beneficient carries a market capitalization of 1.32M, placing it among publicly traded companies globally. Its enterprise value stands at 206.15M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.32M |
| Enterprise Value | 206.15M |
Beneficient currently has 14.80M shares outstanding.
| Shares Outstanding | 14.80M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| EV / Sales | N/A |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 12.91 |
Beneficient maintains a current ratio of 0.12, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -103.44, indicating conservative leverage, while an interest coverage ratio of -2.53 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.12 |
| Quick Ratio | 0.12 |
| Debt / Equity | -103.44 |
| Debt / EBITDA | -1.91 |
| Interest Coverage | -2.53 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -23.22 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 95.15 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
| Income Tax | 214,000.00 |
| Effective Tax Rate | N/A |
Beneficient's stock has declined approximately -37.59398% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | -37.59398% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Average Volume (20 Days) | N/A |
EBITDA reached -50.56M, while operating income came in at -51.18M.
| Revenue | -14.34M |
| Gross Profit | -25.68M |
| Operating Income | -51.18M |
| Pretax Income | -72.24M |
| Net Income | -29.13M |
| EBITDA | -50.56M |
| EBIT | -51.18M |
| Earnings Per Share (EPS) | N/A |
Beneficient holds 7.63M in cash and equivalents against 96.78M in total debt, resulting in a net debt position of 91.20M. Total book value stands at -210.40M, with working capital of -53.58M providing operational flexibility.
| Cash & Cash Equivalents | 7.63M |
| Total Debt | 96.78M |
| Net Debt | 91.20M |
| Equity (Book Value) | -210.40M |
| Book Value Per Share | -14.22 |
| Working Capital | -53.58M |
Beneficient produced -31.99M in operating cash flow over the past twelve months.
| Operating Cash Flow | -31.99M |
| Capital Expenditures | N/A |
| Free Cash Flow | -31.99M |
| FCF Per Share | N/A |
Beneficient operates with a gross margin of 179.10, reflecting its pricing power and cost economics. The operating margin of 357.01 and net profit margin of 203.20 provide insight into operational efficiency.
| Gross Margin | 179.10 |
| Operating Margin | 357.01 |
| Pretax Margin | 503.91 |
| Profit Margin | 203.20 |
| EBITDA Margin | 352.63 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 7,394.33 |
| FCF Yield | N/A |
Beneficient posts an Altman Z-Score of -13.24, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -13.24 |